Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ANIP
#2090
ANI Pharmaceuticals, Inc.
76.480
0
USD
-2.31%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-2.31%
Changement Mensuel
+8.07%
Evolution sur 6 mois
-19.18%
Changement Annuel
-19.18%
Clôture Précédente
78.290
0
Open
76.480
0
Bid
Ask
Low
76.480
0
High
76.480
0
Volume
49
Marchés
Actions des Marchés US
Soins de Santé
ANIP
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
21.76 M
21.65 M
21.69 M
22.46 M
22.41 M
—
Valuation ratios
Enterprise value
1.38 B
1.62 B
1.51 B
2.11 B
1.79 B
7.03 B
Price to earnings ratio
-53.15
-57.22
-97.39
52.95
23.78
-77.89
Price to sales ratio
1.74
1.94
1.73
2.24
1.9
7.81
Price to cash flow ratio
16.68
16.29
9.4
10.92
9.05
45.65
Price to book ratio
2.65
0.78
0.77
1.05
3.1
5.7
Enterprise value to EBITDA ratio
10.05
8.4
6.92
7.31
6.05
28.68
Profitability ratios
Return on assets %
-0.01
0.01
0.01
0.02
0.02
0.06
Return on equity %
-0.03
0.04
0.02
0.05
0.05
0.16
Return on invested capital %
-1.22
7.62
4.23
10.78
11.36
34
Gross margin %
57.87
62.95
64.7
59.01
59.42
246.07
Operating margin %
-2.3
13.29
6.57
15.91
14.07
49.84
EBITDA margin %
41.37
35.57
27.73
34.95
56.76
155
Net margin %
-5.39
7.95
4.04
11.68
11.13
34.81
Liquidity ratios
Quick ratio
2.02
1.98
1.96
2.04
2.19
8.17
Current ratio
2.72
2.66
2.54
2.58
2.71
10.49
Inventory turnover
0.56
0.53
0.54
0.66
0.69
2.42
Asset turnover
0.15
0.15
0.16
0.17
0.17
0.65
Solvency ratios
Debt to assets ratio
0.25
0.24
0.23
0.22
0.21
0.92
Debt to equity ratio
0.79
0.76
0.72
0.62
0.57
2.67
Long term debt to total assets ratio
0.24
0.24
0.22
0.21
0.2
0.87
Long term debt to total equity ratio
0.77
0.73
0.69
0.59
0.54
2.55
Per share metrics
Operating cash flow per share
0.82
1.75
3.73
2.09
1.43
9
EBIT per share
-0.23
1.31
0.68
1.72
1.64
5.35
EBITDA per share
4.08
3.5
2.89
3.77
6.61
16.76
Total debt per share
16.49
15.79
15.5
14.84
14.57
60.69
Cash per share
7.5
7.47
10.72
12.45
13.45
44.1
Net current asset value per share
27.32
26.75
29.67
33.11
35.48
125.02
Tangible book value per share
-10.26
-9.01
-7.1
-2.68
-0.06
-18.84
Working capital per share
17.29
16.69
18.01
20.28
22.38
77.36
Book value per share
20.9
20.88
21.51
23.98
25.47
91.84
Nouvelles
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
ANI Pharmaceuticals lance des comprimés génériques de mononitrate d’isosorbide
ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD